4-(3-氯苯基)-2-氨基噻唑 | 90533-23-6

• 物质功能分类: 有机原料 - 杂环化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 4-(3-氯苯基)-2-氨基噻唑
• 中文别名: 4-(3-氯苯基)噻唑-2-基胺
• 英文名称: 4-(3-chlorophenyl)thiazol-2-amine
• 英文别名: 2-amino-4-(m-chlorophenyl)thiazole；4-(3-chlorophenyl)-1,3-thiazol-2-amine
• CAS: 90533-23-6
• 化学式: C₉H₇ClN₂S
• mdl: MFCD02664012
• 分子量: 210.687
• InChiKey: QSEDBGULKWHVNE-UHFFFAOYSA-N

物化性质

• 熔点：
  112 °C(Solv: ethanol (64-17-5))
• 沸点：
  394.2±17.0 °C(Predicted)
• 密度：
  1.389±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  67.2
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2934100090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  应将样品存放在室温、避光的环境中，并保存在惰性气体中。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-(3-Chlorophenyl)thiazol-2-amine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-(3-Chlorophenyl)thiazol-2-amine
CAS number: 90533-23-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H7ClN2S
Molecular weight: 210.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(3-氯苯基)-2-氨基噻唑 在 N-溴代丁二酰亚胺(NBS) 、 caesium carbonate 作用下， 以 四氢呋喃 、 丙酮 为溶剂， 生成 5-(4-chlorophenoxy)-4-(3-chlorophenyl)thiazol-2-amine
  参考文献：
  名称：

  [EN] COMPOUNDS USEFUL AS RETINOID-RELATED ORPHAN RECEPTOR GAMMA MODULATORS
  [FR] COMPOSÉS UTILES EN TANT QUE MODULATEURS DU RÉCEPTEUR APPARENTÉ AU RÉCEPTEUR DES RÉTINOÏDES GAMMA

  摘要：

  揭示了与视黄醇相关孤儿受体γ（RORγ）调节剂的化学式（I）及其在治疗由RORγ介导的疾病中的应用，其中基团具有发明中定义的含义。

  公开号：

  WO2012100734A1
• 作为产物：
  描述：

  3-氯苯乙酮 在 copper(ll) bromide 作用下， 以 乙醇 、 乙酸乙酯 为溶剂， 反应 5.0h， 生成 4-(3-氯苯基)-2-氨基噻唑
  参考文献：
  名称：

  N-(5-Phenylthiazol-2-yl) 丙烯酰胺作为新型强效谷胱甘肽 S-转移酶 Omega 1 抑制剂的基于结构的设计。

  摘要：

  使用报道的谷胱甘肽 S-转移酶 omega 1 (GSTO1-1) 共晶结构，我们设计并合成了与催化位点上的 Cys32 共价结合的含丙烯酰胺化合物。从噻唑衍生物 10 (GSTO1-1 IC50 = 0.6 μM) 开始，合成化合物 18 并与 GSTO1 共结晶。对命中化合物 10 的酰胺部分的修饰显着增加了 GSTO1-1 抑制效力。我们解决了带有与 GSTO1 结合的酰胺侧链的新衍生物 37 和 44 的共晶结构。与 18 相比，这些新结构显示了抑制剂 37 和 44 的苯基噻唑核心的重新定向。在 GSTO1:44 的共晶结构的指导下，设计了类似物 49，从而产生了最有效的 GSTO1-1 抑制剂（IC50 = 0.22 ± 0.02 nM) 迄今为止已知。

  DOI：

  10.1021/acs.jmedchem.8b01960

文献信息

• Synthesis of 2-aminothiazoles from styrene derivatives mediated by 1,3-dibromo-5,5-dimethylhydrantoin (DBH)
  作者：Chunhua Ma、Yuqi Miao、Minghao Zhao、Ping Wu、Jianglu Zhou、Zhi Li、Xilei Xie、Wei Zhang

  DOI：10.1016/j.tet.2018.05.021

  日期：2018.7

  An efficient procedure for the synthesis of 2-aminothiazoles via DBH-mediated oxidative cyclization of styrenes and thioureas is reported. Various alkenes were successfully transformed to the corresponding 2-aminothiazoles in yields of 10–81% via a two-step one-pot manner using DBH as both the bromine source and oxidant. The method can be readily carried out in gram-scale and successfully applied to

  据报道，通过DBH介导的苯乙烯和硫脲的氧化环化合成2-氨基噻唑的有效方法。使用DBH作为溴源和氧化剂，通过两步一锅法成功地将各种烯烃成功转化为相应的2-氨基噻唑，产率为10-81％。该方法可以容易地以克为单位进行，并且成功地用于以苯乙烯为起始原料的抗炎药fanetizole的合成。
• Synthesis of 2-aminothiazoles via rhodium-catalyzed carbenoid insertion/annulation of sulfoxonium ylides with thioureas
  作者：Yuncan Chen、Shan Lv、Ruizhi Lai、Yingying Xu、Xin Huang、Jianglian Li、Guanghui Lv、Yong Wu

  DOI：10.1016/j.cclet.2021.02.052

  日期：2021.8

  Sulfoxonium ylides as carbene precursors couple smoothly with thioureas in the presence of 5 mol% of rhodium(II) acetate dimmer via carbenoid insertion to afford the corresponding 2-aminothiazoles with high chemoselectivity, providing a facile and efficient approach to access a variety of 2-aminothiazole derivatives with good functional groups tolerance.

  在 5 mol% 的乙酸铑（II）二聚体的存在下，作为卡宾前体的磺基叶立德通过卡宾插入提供了相应的具有高化学选择性的 2-氨基噻唑，提供了一种简单有效的方法来获得各种 2-具有良好官能团耐受性的氨基噻唑衍生物。
• 一种5-氟-2,4-嘧啶二胺类化合物及其制备与 应用
  申请人：浙江工业大学

  公开号：CN111116575B

  公开（公告）日：2021-06-15

  本发明公开了一类具有式(I)结构的5‑氟‑2,4‑嘧啶二胺类化合物、其制备方法及其在制备抗肿瘤药物中的应用，所述的抗肿瘤药物为治疗肝癌、肺癌或白血病的药物。本发明提供的式(I)化合物具有良好抗肿瘤活性，为新药筛选提供了基础；对HepG‑2细胞株、A549细胞株、HL‑60细胞株具有显著的抑制作用；并且，本发明提供了式(I)的制备方法，制备方法简单，有利于工业生产。
• Novel synthesis of <scp>2‐Aminothiazoles</scp> via Fe( <scp>III</scp> )‐Iodine‐catalyzed Hantzsch‐type condensation
  作者：Sankuviruthiyil M. Ujwaldev、Nissy Ann Harry、Mohan Neetha、Gopinathan Anilkumar

  DOI：10.1002/jhet.4166

  日期：2021.2

  A novel iron‐iodine catalyzed one pot synthesis of 2‐aminothiazoles from methyl aryl ketones and thiourea is demonstrated. This protocol can be considered as a catalyzed version of the classical Hantzsch aminothiazole synthesis as it enables the in situ generation of α‐iodoketones in the reaction medium using catalytic amount of iodine leading to Hantzsch condensation with thiourea. The supply of iodine

  演示了一种新颖的铁碘催化从甲基芳基酮和硫脲一锅合成2-氨基噻唑的方法。该方案可被视为经典Hantzsch氨基噻唑合成的催化形式，因为它能够利用催化量的碘在反应介质中原位生成α-碘酮，从而导致Hantzsch与硫脲缩合。通过使用催化量的铁可以确保多个催化循环的碘供应，因为它可以使碘化物氧化为碘。通过合成来自不同酮和硫脲的各种2-氨基噻唑，该协议的通用性在本手稿中也得到了很好的确立。
• TGF-Beta Inhibitors
  申请人：Rigel Pharmaceuticals, Inc.

  公开号：US20160257690A1

  公开（公告）日：2016-09-08

  Disclosed are imidazole and thiazole compounds, as well as pharmaceutical compositions and methods of use thereof. One embodiment is a compound having the structure and pharmaceutically acceptable salts, prodrugs and N-oxides thereof (and solvates and hydrates thereof), wherein X, A, Z, R 1 and R′ are as described herein. In certain embodiments, a compound disclosed herein inhibits TGF-β, and can be used to treat disease by blocking TGF-β signaling.

  本文披露了咪唑和噻唑化合物，以及其药物组合物和使用方法。一个实施例是具有以下结构的化合物 及其药用可接受盐、前药和N-氧化物（以及其溶剂和水合物），其中X、A、Z、R1和R'如本文所述。在某些实施例中，本文披露的化合物抑制TGF-β，并可用于通过阻断TGF-β信号传导来治疗疾病。